Journal of Molecular Medicine

, Volume 74, Issue 1, pp 35–42

Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors

  • H. Friess
  • P. Berberat
  • M. Schilling
  • J. Kunz
  • M. W. Büchler
  • M. Korc
Review

DOI: 10.1007/BF00202070

Cite this article as:
Friess, H., Berberat, P., Schilling, M. et al. J Mol Med (1996) 74: 35. doi:10.1007/BF00202070
  • 54 Views

Abstract

Molecular alterations play a key role in the pathogenesis of gastrointestinal cancers. In the present paper we describe relevant molecular alterations in human pancreatic adenocarcinomas. Overexpression of growth factor receptors (EGF receptor, c-erbB2, c-erbB3, TGFβ receptor I–III), growth factors (EGF, TGFα, TGFβ-1-3, aFGF, bFGF), adhesion molecules (ICAM-1, ELAM-1) and gene mutations (p53, K-ras, DCC, APC) are present in a significant number of these tumors. These changes stimulate tumor growth and enhance the metastatic behavior of pancreatic cancer cells and thereby may contribute to shorter postoperative survival following tumor resection.

Key words

Pancreatic cancerGrowth factor receptorsGrowth factorsAdhesion moleculesGene mutations

Abbreviations

EGF

Epidermal growth factor

ELAM

Endothelial leukocyte adhesion molecule

aFGF

Acidic fibroblast growth factor

bFGF

Basic fibroblast growth factor

HER

Human EGF-receptor

ICAM

Intercellular adhesion molecule

TGF

Transforming growth factor

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • H. Friess
    • 1
  • P. Berberat
    • 1
  • M. Schilling
    • 1
  • J. Kunz
    • 1
  • M. W. Büchler
    • 1
  • M. Korc
    • 2
  1. 1.Department of Visceral and Transplantation SurgeryUniversity of BerneBerneSwitzerland
  2. 2.Departments of Medicine and Biological Chemistry, Division of Endocrinology and MetabolismUniversity of CaliforniaIrvineUSA